Last quarter (Q0 0), Zivo Bioscience's total revenue was $31.50K, an increase of 677.78% from the same quarter last year. In Q0, Zivo Bioscience's net income was $-2.27M. See Zivo Bioscience’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	$ 79.02K	$ ―	$ ―	$ 20.00K	$ ―	$ ―
Cost of Revenue	$ ―	$ 1.16M	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ 26.08K	$ -1.16M	$ ―	$ 20.00K	$ ―	$ ―
Operating Expense	$ 13.36M	$ 8.73M	$ 8.65M	$ 8.58M	$ 6.76M	$ -6.13M
Operating Income	$ -13.34M	$ -8.73M	$ -8.65M	$ -8.56M	$ -6.76M	$ -12.54M
Net Non Operating Interest Income Expense	$ -50.71K	$ -13.32K	$ -44.68K	$ -97.63K	$ -2.78M	$ -8.64M
Other Income Expense	$ 378.10K	$ 50.00K	$ 66.08K	$ 452.42K	$ ―	$ ―
Pretax Income	$ -13.61M	$ -8.75M	$ -8.76M	$ -9.13M	$ -11.51M	$ -23.14M
Tax Provision	$ ―	$ -131.41K	$ -400.00B	$ -431.61K	$ ―	$ ―
Earnings From Equity Interest Net Of Tax	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income Common Stockholders	$ -13.61M	$ -8.75M	$ -8.76M	$ -9.11M	$ -11.51M	$ -23.14M
Basic EPS	$ -1.05	$ ―	$ ―	$ -9.60	$ ―	$ ―
Diluted EPS	$ -1.05	$ ―	$ ―	$ -9.60	$ -19.20	$ -7.20
Basic Average Shares	$ 1.74M	$ ―	$ ―	$ 846.21K	$ 575.83K	$ 1.96M
Diluted Average Shares	$ 1.74M	$ ―	$ ―	$ 846.21K	$ 575.83K	$ 3.21M
Dividend Per Share	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Operating Income As Reported	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Basic E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Reported Normalized Diluted E P S	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Rent Expense Supplemental	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
Total Expenses	$ 13.36M	$ 8.73M	$ 8.65M	$ 8.58M	$ 6.76M	$ -6.13M
Net Income From Continuing And Discontinued Operation	$ -13.61M	$ -8.75M	$ -8.76M	$ -9.11M	$ -11.51M	$ -23.14M
Normalized Income	$ -11.62M	$ -8.88M	$ -400.01B	$ ―	$ ―	$ ―
Interest Expense	$ ―	$ ―	$ ―	$ ―	$ ―	$ ―
EBIT	$ -13.56M	$ -8.73M	$ -8.52M	$ -8.56M	$ -11.40M	$ -23.01M
EBITDA	$ -12.28M	$ -8.73M	$ -8.52M	$ -8.56M	$ -9.84M	$ -17.01M

Currency in USD

Zivo Bioscience Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing